IL6R and systemic lupus erythematosus: Nevertheless, the group of Margarete Hibbs reported recently that in another SLE mouse model (Lyn−/− mice), clinical renal function may improve during IL‐6R antibody therapy, despite increased kidney deposits irrespective of treatment time 25.